MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Homer1 polymorphism in patients with Parkinson’s disease and psychosis

A. Lenka, S. Vadivel, R. Christopher, S. Arumugham, S. Hegde, R. Yadav, P. Pal (Washington, DC, USA)

Meeting: MDS Virtual Congress 2020

Abstract Number: 852

Keywords: Hallucinations, Parkinsonism, Psychosis

Category: Parkinson's Disease: Psychiatric Manifestations

Objective: To explore the association of psychosis in Parkinson’s disease with polymorphisms of HOMER1, a gene whose product (Homer1) is responsible for modulating the metabotropic glutamate receptor.

Background: Psychosis is one of the debilitating non-motor symptoms of Parkinson’s disease (PD) which commonly manifests through minor hallucinations (such as passage hallucinations, presence hallucinations, and illusions) and well-formed visual hallucinations. Although polymorphisms of several genes have been explored, the genetic substrates of psychosis in PD remains incompletely understood. Homer1 is a protein with a crucial function in glutamate transmission, which has a potential role in the genesis of hallucinations.

Method: This study recruited a total of 150 Indian subjects- 50 patients with psychosis (PD-P), 50 patients without psychosis (PD-NP), and 50 controls. The groups were matched for age, gender, and education. Single nucleotide polymorphism (SNP) genotyping assay was done by real-time polymerase chain reaction (RT-PCR). Two SNPs of the HOMER1 gene (rs4704559, rs4704560) were studied.

Results: There was no significant difference between any of the genotypes of rs4704559 (AG, GG, AA) between the controls and the overall patient group. Similarly, there was no difference in the frequency of the A and G alleles between the two groups. Similar to the comparison between controls and overall PD group, there was no significant difference between PD-P and PD-NP neither at the genotype level nor at the allele level. For HOMER1-rs4704560 (CC, CT, TT), there was a significant difference in the genotype level as well as in the allele level comparison between PD-P and PD-NP. There was an over-representation of the T-allele of HOMER1-rs4704560 in the PD-P group (p<0.001, Odd’s ratio: 2.62).

Conclusion: The PD-P group had a higher frequency of T-allele compared to the PD-NP group (p<0.001, Odd’s ratio: 2.62). Although previous studies did not find any association of this polymorphism with psychosis in PD, a positive result in our study certainly raises the possibility that T-allele is a risk factor for psychosis in Indian PD patients. This result also reinforces the fact that alterations in the glutamate transmission may have a certain role in the pathogenesis of psychosis in PD.

References: 1) Lenka et.al., Genetic substrates of psychosis in patients with Parkinson’s disease: A critical review; J Neurol Sci. 2016 May 15;364:33-41. 2) Schumacher-Schuh et.al., Association of common genetic variants of HOMER1 gene with levodopa adverse effects in Parkinson’s disease patients. Pharmacogenomics J. 2014 Jun;14(3):289-94.

To cite this abstract in AMA style:

A. Lenka, S. Vadivel, R. Christopher, S. Arumugham, S. Hegde, R. Yadav, P. Pal. Homer1 polymorphism in patients with Parkinson’s disease and psychosis [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/homer1-polymorphism-in-patients-with-parkinsons-disease-and-psychosis/. Accessed June 30, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/homer1-polymorphism-in-patients-with-parkinsons-disease-and-psychosis/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley